REG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>
RNS Number : 0816ROxford Biomedica PLC06 December 2016Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1
Issuer
Oxford BioMedica PLC
2
Reason for notification
Notification relates to DTR 3.1.2R
3
Name of PDMR
Martin Diggle
4
Connected person
Notification relates to following connected persons:
Vulpes Life Sciences Fund
5
Notification in respect of
Notification in respect of holdings of persons in 4 above
6
Description of shares
Oxford BioMedica PLC ordinary shares of 1p each
7
Name of registered shareholders and number of shares
Vulpes Life Sciences Fund - 575,850,000 shares
8
Nature of transaction
Acquisition
9
Number of shares acquired
Vulpes Life Sciences Fund - 833,000 shares
10
Percentage of issued class acquired
Vulpes Life Sciences Fund - 0.03%
11
Shares disposed
N/A
12
Percentage of issued class disposed
N/A
13/14
Price per share of transactions, and date
Vulpes Life Sciences Fund
833,000 shares @ 0.0355 , 05 Dec 2016
15
Total holding following notification and total percentage holding following notification
Vulpes Life Sciences Fund - 547,432,000 shares
17.73%
Vulpes Testudo Fund - 33,333,333 shares
1.08%
16
Date issuer informed
06 Dec 2016
23
Any additional information
None
24
Contact name and telephone number
T. Watts, Chief Financial Officer
Oxford BioMedica
+44 (0)1865 783000
This information is provided by RNSThe company news service from the London Stock ExchangeENDDSHGCBDDSBGBGLL
Recent news on Oxford BioMedica
See all newsREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - 2026 Annual General Meeting notification
AnnouncementREG - Oxford Biomedica PLC - Preliminary results for the year ended 31 Dec 2025
AnnouncementRCS - Oxford Biomedica PLC - Licensing agreement with VVMF
AnnouncementREG - Stock Exch Notice - Admission to Trading - 09/03/2026
Announcement